Federal food and drug officials dropped draft guidance for clinical research related to cannabis and cannabis-derived products.
FDA’s new guidance on cannabis drug development won’t define path for CBD products, legal experts say is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
From FDA’s new guidance on cannabis drug development won’t define path for CBD products, legal experts say on CBD Products & CBD Business News – Hemp Industry Daily.
This was autoposted by IFTTT. To find out more, read my post about news articles.
No comments:
Post a Comment